Advisory Board
The board is comprised of experts from across the spectrum of healthcare who are available to advise and consult with Xchange Challenge finalists on topics ranging from business strategy to drug and medical device discovery and development.
Cure Xchange Advisory Board
Seema Kumar
Chief Executive Officer
Rick A. Bright, PhD
CEO, Bright Global Health
Daniel Kraft, MD
Founder and Chair, NextMed Health
Daniella Foster, MA
Executive Board Member and Senior Vice President of Public Affairs, Science and Sustainability for Bayer Consumer Health
Gregory Petsko, DPhil
Professor of Biomedical Engineering, Cornell University
Maria Luisa Pineda, PhD
Vice Chair, The Alliance for Artificial Intelligence in Healthcare; CEO and Cofounder, Envisagenics, Inc.
Mary Woolley
President and CEO, Research!America
Susan Rosenthal, MBA
Senior Vice President, Life Sciences and Healthcare at New York City Economic Development Corporation
Joe Wilson, MBA
Founder and Managing Partner, Undeterred Capital
Nolan Townsend, MBA
CEO, LEXEO Therapeutics
John Mattison, MD
Operating Partner, Chief Medical information Officer, Arsenal Capital Partners; UC San Diego Scholar in Residence: Safety and Ethics for AI and Advanced Technologies
Susan Whitehead, JD
Independent Non-Profit Organization Management Professional
Huijun Wang, PhD
Head of Computational Drug Design, Deerfield Discovery and Development (3DC)
Gustavo Stolovitzky, PhD
Founder, DREAM Challenges
Elliot Menschik, MD, PhD
Repeat Founder and CEO and Startup Investor in Biotech Sector
Ramesh Raskar, PhD
Associate Professor and Director of the Camera Culture Research Group at MIT Media Lab
Gillian Sandler
Partner, Galapont, LLC